ID   DL-8
AC   CVCL_J399
DR   Wikidata; Q54831139
RX   PubMed=2159524;
RX   PubMed=6350167;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
RX   PubMed=2159524; DOI=10.1128/JVI.64.6.2474-2483.1990; PMCID=PMC249422;
RA   Yanagawa, Shin-ichi
RA   Murakami, Akira
RA   Tanaka, Harutaka
RT   "Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire
RT   a selective advantage in lymphocytes by alteration in the U3 region of
RT   the long terminal repeat.";
RL   J. Virol. 64:2474-2483(1990).
//
RX   PubMed=6350167; PMCID=PMC1454228;
RA   Suzuki, Takayo
RA   Miyama-Inaba, Muneo
RA   Masuda, Tohru
RA   Uchino, Haruto
RA   Murakami, Akira
RA   Tanaka, Harutaka
RT   "Suppressive B-cell factor (SBF) produced by FcR-bearing B cells;
RT   suppression of B, but not non-B-cell proliferation.";
RL   Immunology 50:149-157(1983).
//